Xiang Liao

Direttore/Membro del Consiglio presso CLOVER BIOPHARMACEUTICALS, LTD.

Patrimonio netto: 13 266 $ in data 30/04/2024

59 anni

Consumer Services

Health Technology

Profilo

Xiang Liao is currently the Chief Executive Officer at Novastream Biotech Co. Ltd.
and an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd.
Previously, he worked as the Director of Corporate Development at Sanofi Pasteur from 1992 to 2007.
Mr. Liao holds an MBA from The Trustees of Columbia University in The City of New York, a graduate degree from the University of Scranton, and an undergraduate degree from West China University of Medical Sciences.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
CLOVER BIOPHARMACEUTICALS LTD. 0.02%	02/04/2024	300 750 ( 0.02% )	13 266 $	30/04/2024

Posizioni attive di Xiang Liao

Società	Posizione	Inizio
CLOVER BIOPHARMACEUTICALS, LTD.	Direttore/Membro del Consiglio	19/04/2021
Novastream Biotech Co. Ltd.	Amministratore Delegato	01/03/2012

Tutte le posizioni attive di Xiang Liao

Precedenti posizioni note di Xiang Liao

Società	Posizione	Fine
Sanofi Pasteur Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.	Corporate Officer/Principal	01/12/2007

Vedi nel dettaglio l'esperienza di Xiang Liao

Formazione di Xiang Liao

West China University of Medical Sciences	Undergraduate Degree
University of Scranton	Graduate Degree
The Trustees of Columbia University in The City of New York	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Xiang Liao

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CLOVER BIOPHARMACEUTICALS, LTD.	Health Technology

Aziende private	2
Novastream Biotech Co. Ltd.
Sanofi Pasteur Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.	Health Technology

Vedi le connessioni aziendali